Concepedia

Publication | Closed Access

AMPLIFICATION OF IMMUNOLOGICAL FUNCTIONS BY SUBCUTANEOUS INJECTION OF INTERMEDIATE-HIGH DOSE INTERLEUKIN-2 FOR 2 YEARS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHILDREN WITH STAGE IV NEUROBLASTOMA

DOI

14

Citations

8

References

2000

Year

Amos Toren, Arnon Nagler, Galit Rozenfeld-Granot, M Levanon, Jacqueline Davidson, Bella Bielorai, Chaim Kaplinsky, Dafna Meitar, Mathilda Mandel, Aliza Ackerstein,
Transplantation

Abstract

Immunotherapy with s.c. intermediate-high dose IL-2 is feasible and results in expansion of T cells and in stimulation of killing activity against several targets including in some cases, neuroblastoma tumor cells.

References

YearCitations

Page 1